Affiliation:
1. Northwell Health New Hyde Park New York USA
2. Department of Otolaryngology – Head & Neck Surgery Lenox Hill Hospital New York New York USA
Abstract
AbstractBackgroundThis scoping review aims to review cases of extranodal marginal zone lymphoma (MZL) of the larynx to establish best management practices for this rare clinical entity.MethodsIn this paper, we report a case of laryngeal MZL, in accordance with CARE guidelines. We then performed a scoping review according to PRISMA‐ScR criteria of published cases of MZL involving the larynx. The following data were collected for each case: age, sex, size, location(s) involved, stage, treatment, follow‐up, and recurrence duration.ResultsSixty‐six patients with laryngeal MZL, first reported in 1990, were identified. Characterized by its low‐grade histological appearance and indolent course, laryngeal MZL is generally confined to the larynx and has an excellent prognosis with radiation used as first‐line therapy.ConclusionsIt is imperative for clinicians to consider lymphoma in the differential diagnosis of a laryngeal tumor from any subsite, as certain pathologies may carry high risks of metastasis.